Limited Competition: Clinical and Translational Science Awards (CTSA) Program: Collaborative and Innovative Acceleration Award
Agency: National Institutes of Health
- 93.350 -- National Center for Advancing Translational Sciences
Forecasted opportunityLast Updated: Jul 20, 2026
Important dates
- Forecasted post date: September 1, 2026
- Forecasted application due date: February 16, 2027
- Forecasted award date: December 15, 2027
- Forecasted project start date: December 15, 2027
- Fiscal Year: 2028
Award details
- Expected project funding: Not specified
- Expected awards: Not specified
Award min.
Not specified
Award max.
Not specified
- Funding opportunity number:PAR-28-008
- Cost sharing or matching requirement:No
- Funding instrument type:
- Cooperative agreement
- Opportunity Category:Discretionary
- Opportunity Category Explanation:Not specified
- Category of Funding Activity:
- Health
- Category Explanation:Not specified
History
- Forecast posted date: July 20, 2026
- Archive date: Not specified
- Version: 1
Summary
The purpose of the Congressionally mandated Clinical and Translational Science Award (CTSA) Program is to accelerate the translation of scientific discoveries into treatments, diagnostics, and health interventions that improve patient and public health by funding and coordinating a national network of academic medical centers that provide the infrastructure, expertise, training, and collaboration needed to move discoveries from the laboratory into clinical practice and community health. The purpose of the reissuance of the Collaborative and Innovative Acceleration Award for the CTSA Program Notice of Funding Opportunity (NOFO) is to support the collaborative development of innovative approaches, technologies, or models that synergistically enhance the impact of research, advance translational science, and bring more treatments for all people more quickly.
This is a Forecast for a Limited Competition that will invite application(s) from eligible organization(s) to apply. Please see Eligibility Section for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered for funding.
Eligibility
Miscellaneous
- Other
Additional information on eligibility
Documents
No documents are currently available.
Agency contact information
Email: ctsa_collaborativeinnovation@mail.nih.gov
ctsa_collaborativeinnovation@mail.nih.gov
Link to additional information
No additional information is available
HHS.gov
An official website of the U.S. Department of Health and Human Services
